Last $857.59 MXN
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:09 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5 Basel Street

Petach Tikva, 49131


Phone: 972 3 926 7267

Fax: 972 3 923 4050

dium channels found in sensory nerve endings that can increase in chronic painful conditions, and is in Phase II clinical development for a variety of pain-related disorders. In 2011, the company formed a consumer health care joint venture with P&G, combining its OTC pharmaceutical businesses in all markets outside North America. The company manufactures products to supply the joint venture’s markets, as well as P&G’s existing North American OTC business. The company owns 49% of the joint venture, and P&G owns 51%. As of December 2012, the OTC products of Cephalon (Mepha) were included in the joint venture. Dispositions In January 2013, the company sold its U.S.-based animal health business, exiting the business. Significant Events In March 2014, OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. History Teva Pharmaceutical Industries Limited was founded in 1901.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVAN:MM $857.59 MXN 0.00

TEVAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $44.76 USD -0.50
AbbVie Inc $60.35 USD -2.77
Baxter International Inc $70.31 USD -1.07
Eli Lilly & Co $72.00 USD -0.11
Valeant Pharmaceuticals International Inc C$203.17 CAD -0.46
View Industry Companies

Industry Analysis


Industry Average

Valuation TEVAN Industry Range
Price/Earnings 17.9x
Price/Sales 2.4x
Price/Book 2.1x
Price/Cash Flow 20.0x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at